Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study.
about
Interventions for idiopathic intracranial hypertensionInterventions for idiopathic intracranial hypertensionEffect of topiramate on acid-base balance: extent, mechanism and effectsThe diagnosis and management of idiopathic intracranial hypertension and the associated headacheEvolving evidence in adult idiopathic intracranial hypertension: pathophysiology and managementIdiopathic intracranial hypertension: ongoing clinical challenges and future prospectsLow energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort studyCurrent concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults.The idiopathic intracranial hypertension treatment trial: clinical profile at baselinePapilledema: epidemiology, etiology, and clinical managementIntracranial pressure in unresponsive chronic migrainePseudotumor cerebri: brief review of clinical syndrome and imaging findings.High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failureAdvancement in idiopathic intracranial hypertension pathogenesis: focus on sinus venous stenosis.Use of acetazolamide in sulfonamide-allergic patients with neurologic channelopathies.Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?Pseudotumor cerebri: an update on treatment options.Cerebral venous sinus stenting for pseudotumor cerebri: A review.Topiramate and the vision: a systematic review.Inhibition of carbonic anhydrase reduces brain injury after intracerebral hemorrhagePremedication With Single Dose of Acetazolamide for the Control of Referral Shoulder Pain After Laparoscopic CholecystectomyUpdate on the pathophysiology and management of idiopathic intracranial hypertension.Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing managementAn update on idiopathic intracranial hypertension.Stable overexpression of DNA fragmentation factor in T-47D cells: sensitization of breast cancer cells to apoptosis in response to acetazolamide and sulfabenzamide.More than meets the eye? Redefining idiopathic intracranial hypertension.Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.Headache attributable to nonvascular intracranial disorders.Sinus venous stenosis, intracranial hypertension and progression of primary headaches.High-pressure headaches: idiopathic intracranial hypertension and its mimics.Diagnosis and treatment of idiopathic intracranial hypertension (IIH) in children and adolescents.Idiopathic intracranial hypertension; research progress and emerging themes.Rebound intracranial hypertension: a complication of epidural blood patching for intracranial hypotension.High-pressure headaches, low-pressure syndromes, and CSF leaks: diagnosis and management.Fifteen-minute consultation: the child with idiopathic intracranial hypertension.Headache and the pseudotumor cerebri syndrome.Safety of topiramate for treating migraines.Idiopathic intracranial hypertension: Contemporary review and implications for the otolaryngologist.A randomised controlled trial of treatment for idiopathic intracranial hypertension.Optic Nerve.
P2860
Q24187976-4BCD6572-0787-4182-92F8-A7825CFA6420Q24246672-A1E4ACE4-3E8E-418F-A28A-5F3B979BD803Q24643009-289158E4-B697-467C-967E-19B1191C1640Q26745691-77B844A0-5DEC-4EB0-A8F0-176EC5D46F55Q26765034-87709F1E-03B8-4A44-BF06-B2AD9C40165FQ26765260-06332C93-D7D2-44DD-9F18-16C93F2A26D9Q28750454-EAFC06DD-4F6C-4BC5-9CCB-1868C8CB9C70Q30238677-810C6435-1DD0-495B-8B50-18A7F7494F5DQ30393845-4E8DF87B-0DB2-4D8A-B99A-C85594C8DFC9Q33585419-7FED7CCF-5A4C-4819-B23B-8C2833141A3AQ33898980-C4897769-D068-444A-B5DB-498D0312768FQ33934914-E1FF20D7-BD67-48FE-9632-180193BAC9CFQ34091115-CD9A650B-5BDC-4058-83DE-8EE5DF65BACDQ34115078-3653BB2F-F44D-48EC-9E53-ABA612BBF0ABQ34239870-F5E97AC8-385B-4052-B4BE-37BAD2911CEAQ34383339-1D1FE50E-BD47-42B3-8FA2-EC4B9CE6F516Q34780008-7A025E51-9936-4AD9-BA4B-4B1EED4CA633Q35040617-278E283A-ADD7-4A2E-BEE9-C5728C34C197Q35682062-7083D8A4-FDEA-4BAD-90DF-B59E0D79FE8DQ35801721-DA7C2CAF-BFEC-4765-A0BA-11B6CB07E9FAQ36397619-15125896-204A-4F75-A457-68050D94919BQ36529652-FA75BD52-B790-4AD4-BB96-8FE03693C456Q36561779-1B45BB15-7A82-4C94-995E-707B075DD885Q36907332-3D3F0612-1D64-45A7-BC4E-249C9B04E0FBQ37554712-E859505C-ACA7-46A2-B8EF-7D5151567B8EQ37768173-6E1DD5CF-FB7E-4F69-91B1-571733882C57Q37779809-9335DCE7-74C1-4444-8D25-7EDB9C6CC670Q37860205-42C66ABE-A5F4-4E59-8465-639353D8B2EBQ38014279-4AF0C0B9-D3E9-4B55-A678-AA8418809091Q38061011-3A31089D-D98B-498D-987E-6ABD12F5C301Q38077706-A7234959-3328-4900-A265-F576974B09A8Q38148469-91CA5D3C-B651-47F3-8C3C-715737F16B4FQ38177157-ECB7D497-FD93-419F-9EBE-0206EB35FB61Q38179089-AB6BF540-2B3F-4CCA-B616-0EFEEC928436Q38199342-71DE475D-E1D3-47FC-80D5-6FA78363290BQ38236305-4F9A069E-2F3E-4189-9994-C50B5DBF9D5BQ38237259-1D6EF81C-6BA5-418D-A1DD-02034FB95123Q38871789-E8247F35-5C19-4007-8C49-196AE99E784DQ39805081-4F4836E0-1C12-4E29-B01D-CD209920C6BBQ40481942-5D5E2CF1-EAAF-4F55-98F8-3ACDEE9003E8
P2860
Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Treatment of idiopathic intrac ...... zolamide, an open-label study.
@ast
Treatment of idiopathic intrac ...... zolamide, an open-label study.
@en
Treatment of idiopathic intrac ...... zolamide, an open-label study.
@nl
type
label
Treatment of idiopathic intrac ...... zolamide, an open-label study.
@ast
Treatment of idiopathic intrac ...... zolamide, an open-label study.
@en
Treatment of idiopathic intrac ...... zolamide, an open-label study.
@nl
prefLabel
Treatment of idiopathic intrac ...... zolamide, an open-label study.
@ast
Treatment of idiopathic intrac ...... zolamide, an open-label study.
@en
Treatment of idiopathic intrac ...... zolamide, an open-label study.
@nl
P2093
P2860
P1476
Treatment of idiopathic intrac ...... zolamide, an open-label study.
@en
P2093
P2860
P304
P356
10.1111/J.1600-0404.2007.00905.X
P407
P577
2007-11-01T00:00:00Z